Cargando…

Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia

Primary myelofibrosis (PMF) is a type of cloned myeloproliferative neoplasm stemming from haematopoietic stem cells, and tends to transform to acute myeloid leukaemia (AML) in approximately 10–20% of cases over a 10-year period. The transformation into AML has a poor prognosis, with a median overall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yan, Lin, Rongrong, Zhou, Guangquan, Liu, Yue, Dong, Weimin, Cao, Yang, Xie, Xiaobao, Gu, Weiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381513/ https://www.ncbi.nlm.nih.gov/pubmed/30616420 http://dx.doi.org/10.1177/0300060518820147

Ejemplares similares

All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex
por: Wang, Lu, et al.
Publicado: (2022)

All-trans retinoic acid enhances the effect of 5-aza-2′-deoxycytidine on p16INK4a demethylation, and the two drugs synergistically activate retinoic acid receptor β gene expression in the human erythroleukemia K562 cell line
por: XIANG, LILI, et al.
Publicado: (2014)

A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide
por: Chen, Xue, et al.
Publicado: (2019)

Activity of decitabine combined with all-trans retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER)
por: Rummelt, Christoph, et al.
Publicado: (2023)

Long‐term remission of extramedullary cutaneous relapse of acute myeloid leukaemia (leukaemia cutis) treated with decitabine‐venetoclax
por: Maravalle, Denise, et al.
Publicado: (2022)

The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation
por: Meier, Ruth, et al.
Publicado: (2022)

Anti-PML-RARα shRNA sensitises promyelocytic leukaemia cells to all-trans retinoic acid
por: Casey, Nicholas P, et al.
Publicado: (2012)

Thrombocytosis in a male patient with acute promyelocytic leukaemia during all-trans retinoic (ATRA) acid treatment
por: Aldapt, Mahmood B., et al.
Publicado: (2018)

Development of JAK2 positive myelofibrosis on a background of chronic myeloid leukaemia
por: Mullen, Christopher Gerard, et al.
Publicado: (2022)

Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
por: Boutzen, Héléna, et al.
Publicado: (2016)

Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1
por: Paubelle, Etienne, et al.
Publicado: (2019)

Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes
Publicado: (2022)

All trans-retinoic acid (ATRA) induces re-differentiation of early transformed breast epithelial cells
por: ARISI, MARIA F., et al.
Publicado: (2014)

Two cases of differentiation syndrome with ocular manifestations in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and arsenic trioxide
por: Newman, A.R., et al.
Publicado: (2018)

The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid
por: Steinmetz, Birgit, et al.
Publicado: (2014)

Targeting of myeloid-derived suppressor cells by all-trans retinoic acid as host-directed therapy for human tuberculosis
por: Leukes, Vinzeigh N., et al.
Publicado: (2021)

Use of Azacitidine or Decitabine for the Up-Front Setting in Acute Myeloid Leukaemia: A Systematic Review and Meta-Analysis
por: Saiz-Rodríguez, Miriam, et al.
Publicado: (2021)

Pharmacokinetics of All‐trans Retinoic Acid in Pediatric Patients with Leukemia
por: Takitani, Kimitaka, et al.
Publicado: (1995)

Transdifferentiation of Myoblasts Into Adipocytes by All-Trans-Retinoic Acid in Avian
por: Kim, Dong-Hwan, et al.
Publicado: (2022)

Potential Therapeutic Effect of All-Trans Retinoic Acid on Atherosclerosis
por: Deng, Qile, et al.
Publicado: (2022)

Deregulation of All-Trans Retinoic Acid Signaling and Development in Cancer
por: Brown, Geoffrey
Publicado: (2023)

All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment
por: Su, Meng, et al.
Publicado: (2015)

All-Trans Retinoic Acid Synergizes with Enasidenib to Induce Differentiation of IDH2-Mutant Acute Myeloid Leukemia Cells
por: Kim, Yundeok, et al.
Publicado: (2020)

Acute Myeloid Leukemia Transformation from Myelofibrosis Upon Remission of an Orbital Myeloid Sarcoma – A Case Report
por: Chen, Nancy, et al.
Publicado: (2021)

Effect of all-trans retinoic acid on casein and fatty acid synthesis in MAC-T cells
por: Liao, Xian-Dong, et al.
Publicado: (2020)

Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells
por: Armstrong, J L, et al.
Publicado: (2005)

All-Trans Retinoic Acid in Combination with Primaquine Clears Pneumocystis Infection
por: Lei, Guang-Sheng, et al.
Publicado: (2013)

Emerging Cancer Epigenetic Mechanisms Regulated by All-Trans Retinoic Acid
por: Rossetti, Stefano, et al.
Publicado: (2020)

All trans retinoic acid as a host-directed immunotherapy for tuberculosis
por: Bahlool, Ahmad Z., et al.
Publicado: (2022)

All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis
por: Ma, Yafang, et al.
Publicado: (2016)

Hepatic retinoic acid receptor alpha mediates all‐trans retinoic acid's effect on diet‐induced hepatosteatosis
por: Cassim Bawa, Fathima N., et al.
Publicado: (2022)

The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
por: Fredly, Hanne, et al.
Publicado: (2013)

The Addition of All-Trans Retinoic Acid to Chemotherapy May Not Improve the Outcome of Patient with NPM1 Mutated Acute Myeloid Leukemia
por: Nazha, Aziz, et al.
Publicado: (2013)

All-Trans Retinoic Acid Enhances Matrix Metalloproteinase 2 Expression and Secretion in Human Myeloid Leukemia THP-1 Cells
por: Vu, Hien Thi, et al.
Publicado: (2018)

All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells
por: Nguyen, Chi H., et al.
Publicado: (2020)

All-Trans-Retinoic Acid Combined With Valproic Acid Can Promote Differentiation in Myeloid Leukemia Cells by an Autophagy Dependent Mechanism
por: Benjamin, Dalyia N., et al.
Publicado: (2022)

Heterodimeric BMP-2/7 Antagonizes the Inhibition of All-Trans Retinoic Acid and Promotes the Osteoblastogenesis
por: Bi, Wenjuan, et al.
Publicado: (2013)

All-Trans Retinoic Acid Ameliorates Myocardial Ischemia/Reperfusion Injury by Reducing Cardiomyocyte Apoptosis
por: Zhu, Zhengbin, et al.
Publicado: (2015)

Severe Wernicke encephalopathy and acute pancreatitis due to all-trans-retinoic acid and arsenic trioxide during treatment of acute promyelocytic leukaemia: a case report
por: Jiang, Yan, et al.
Publicado: (2020)

All-trans retinoic acid upregulates VEGF expression in glioma cells in vitro
por: Liang, Chen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3hjrj69850e9p3r97i5k0t7h88